Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
03/14/2002 | US20020032328 Heterocyclic acylsulfimides, processes for their preparation, compositions comprising them and their use as pesticides |
03/14/2002 | US20020032238 Lowering the plasma level of atherogenic lipoproteins; treating hyperlipidaemias, atherosclerosis or the clinical sequelae thereof, diabetes mellitus, adiposity or pancreatitis |
03/14/2002 | US20020032237 Antipicornaviral compounds, compositions containing them, and methods for their use |
03/14/2002 | US20020032223 Benzamidine derivatives and their use as anti-coagulants |
03/14/2002 | US20020032211 Novel dihydronaphthalene compounds and processes of producing the same |
03/14/2002 | US20020032206 Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
03/14/2002 | US20020032202 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
03/14/2002 | US20020032195 An mono or polycyclic aromatic or heteroaromatic carbamate or urea or thiacarbamoyl derivatives; inhibit production of cytokines involved in inflammatory processes |
03/14/2002 | US20020032191 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors |
03/14/2002 | US20020032189 Amine compounds, their production and use |
03/14/2002 | US20020032186 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
03/14/2002 | US20020032174 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
03/14/2002 | DE10043790A1 Substituierte 1-Aryl-pyridin-2-(thi)one Substituted 1-aryl-pyridin-2- (thi) ones |
03/14/2002 | DE10041402A1 Neue Verbindungen, die Faktor Xa-Aktivität inhibieren Novel compounds which inhibit factor Xa activity |
03/14/2002 | DE10023486C1 Ortho substituierte Anthranilsäureamide und deren Verwendung als Arzneimittel Ortho-substituted anthranilic acid amides and their use as medicaments |
03/14/2002 | CA2421172A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
03/13/2002 | EP1186946A1 Photographic material containing a novel hydrazine type |
03/13/2002 | EP1186597A1 Process for the production of 2-pyridylpyridine derivatives |
03/13/2002 | EP1186596A1 Process for the production of 2-pyridylpyridine derivatives |
03/13/2002 | EP1185540A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents |
03/13/2002 | EP1185521A1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors |
03/13/2002 | EP1185514A1 Pharmaceutical compositions and methods for use |
03/13/2002 | EP1185513A2 Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors |
03/13/2002 | EP1185509A2 INHIBITORS OF FACTOR Xa |
03/13/2002 | EP1185508A2 Inhibitors of factor xa |
03/13/2002 | EP1185506A1 Substituted arylmalonic acid dinitriles as intermediates for the preparation of herbicides |
03/13/2002 | EP1185229A1 Method of treating hair loss |
03/13/2002 | EP0977749B1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
03/13/2002 | EP0837849B1 Pyridine base synthesis |
03/13/2002 | EP0802910B1 Estrogen agonists/antagonists |
03/13/2002 | CN1340049A 4-heterocyclylsulfonamide)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl-or-pyridylpyrimidines as endothelin receptor antagonists |
03/13/2002 | CN1340046A β-丙氨酸衍生物 β- alanine derivatives |
03/13/2002 | CN1340043A Phenylalaninol derivatives |
03/12/2002 | US6355806 Regulators of cell proliferation and differentiation, agents for treating skin-related diseases |
03/12/2002 | US6355805 β3-adrenergic receptor agonists |
03/12/2002 | US6355746 Complexes of mid-transition metals and unsaturated nitrogenous ligands as single-site catalysts |
03/12/2002 | US6355683 Fc receptor modulators and uses thereof |
03/12/2002 | US6355673 Substituted diaminocarboxylic acids |
03/12/2002 | US6355660 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
03/12/2002 | US6355653 Amino-triazolopyridine derivatives |
03/12/2002 | US6355634 Aromatic compounds |
03/12/2002 | US6355443 4-(4-hydroxystyryl) pyridine-containing substrates for an analyte dependent enzyme activation system |
03/12/2002 | US6355394 High contrast silver halide photographic material; graphic arts material for pre-press applications; high gradation, dot quality, exposure latitude and stability on continuous processing |
03/12/2002 | CA2187214C Aminostilbazole derivative and medicine |
03/07/2002 | WO2002018377A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
03/07/2002 | WO2002018340A1 GEM-SUBSTITUTED α v β 3 INTEGRIN ANTAGONISTS |
03/07/2002 | WO2002018339A2 Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same |
03/07/2002 | WO2002018327A2 Guanidinobenzamides as mc4-r agonists |
03/07/2002 | WO2002018321A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
03/07/2002 | WO2002017866A1 Primary intermediates for oxidative coloration of hair |
03/07/2002 | WO2002017712A2 Disubstituted benzenes as insecticides |
03/07/2002 | WO2001089457A3 Thrombopoietin mimetics |
03/07/2002 | WO2001070684A3 Peptidomimetic ligands for cellular receptors and ion channels |
03/07/2002 | WO2001068645A3 N-cyanomethylcarboxamides and their use as protease inhibitors |
03/07/2002 | US20020028946 Process for the preparation of heteroaryl-phenylalanines |
03/07/2002 | US20020028941 Bis-aryliminepyridine complexes with iron or cobalt; methyl aluminoxane coordination catalysts; high yield, selectivity |
03/07/2002 | US20020028933 Thioamide derivatives |
03/07/2002 | US20020028851 Guanylhydrazones and their use to treat inflammatory conditions |
03/07/2002 | US20020028842 Reducing the vomiting side effects of phosphodiesterase inhibitors, e.g. Rolipram, Ariflo, by benzylation by benzyl bromide or a derivative |
03/07/2002 | US20020028837 E.g., (2-(4-methoxyphenethyl))-N'-(2-(5-bromopyridyl))-thiourea; enzyme inhibitors of reverse transcriptase; viricides for HIV infection, including mutant, drug-sensitive, drug and multi-drug resistance strains |
03/07/2002 | US20020028836 Potassium channel openers |
03/07/2002 | US20020028833 Aryl alkenamides derivatives as mcp-1 antagonists |
03/07/2002 | US20020028831 Phenylpyridine derivatives useful as phosphodiesterase inhibitors |
03/07/2002 | US20020028820 4-hydroxy-3-((3,5-difluoro-6-(3 -dimethylaminocarbonylphenoxy)-4-(2-methoxy-4-carboxyphenoxy) pyridin-2-yl)oxy)benzamidine, for example; Factor Xa inhibitors |
03/07/2002 | US20020028818 2-nitrostyryl-1-(naphthylmethyl)sulfone for example |
03/07/2002 | US20020028812 Phenylalanine derivatives |
03/07/2002 | US20020028806 As a pour-on or spot-on on formulation for controlling parasites such as fleas in warm blooded animals; such as 2,2-dimethylbutyric acid, (1-((6-chloro-pyridin-3-ylmethyl)-ethyl-amino)-2-nitrovinyl)-methyl -carbamoyloxy)-methyl ester |
03/07/2002 | US20020028799 Using protease and phospodiesterase inhibitor |
03/07/2002 | US20020027700 Electrochromic display device having high edge sharpness |
03/07/2002 | DE10041428A1 Biphenylderivate Biphenyl |
03/07/2002 | DE10040783A1 AZA-Aminosäurederivate (Faktor X¶a¶-Inhibitoren 15) AZA-amino acid derivatives (factor inhibitors X¶a¶ 15) |
03/07/2002 | DE10035908A1 Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel New heteroaryl derivatives and their use as medicaments |
03/07/2002 | CA2419699A1 Gem-substituted .alpha. v .beta. 3 integrin antagonists |
03/07/2002 | CA2419255A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
03/06/2002 | EP1184376A1 Novel heterocyclic carboxamide derivatives |
03/06/2002 | EP1184375A1 Process for preparing tribromomethylsulfonylpyridine |
03/06/2002 | EP1184374A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
03/06/2002 | EP1184367A1 Amide derivatives |
03/06/2002 | EP1184358A2 Process for treatment and purification of the reaction products obtained by reduction with lithium aluminium hydride |
03/06/2002 | EP1183279A1 Polymerization of ethylene |
03/06/2002 | EP1183235A2 INHIBITORS OF FACTOR Xa |
03/06/2002 | EP1183234A1 INHIBITORS OF FACTOR Xa |
03/06/2002 | EP1183233A2 Bradykinin receptor antagonists |
03/06/2002 | EP1183232A2 Monofluoroalkyl derivatives |
03/06/2002 | EP1183229A1 Glucagon antagonists/inverse agonists |
03/06/2002 | EP1183019A2 Ace-2 inhibiting compounds and methods of use thereof |
03/06/2002 | CN1338452A Substituted phenylamine derivatives |
03/06/2002 | CN1080257C Guanidine derivatives |
03/06/2002 | CN1080251C Dihalopropene compound, insecticide/acaricide containing said dihalopropene compound as active ingredient and intermediate compound for use inproduct of said dihalopropene compounds |
03/05/2002 | US6353111 Which increase insulin secretion in the treatment of type ii diabetes; 2,3-di-substituted trans olefinic n-heteroaromatic or urido propionamides: the substitution at the 2-position being a substituted phenyl group and at the 3-position a |
03/05/2002 | US6353108 1-(3-pyridinyl)-ethanone o-((4-methylphenyl) sulphonyl) oxime forms 3-(2h-azirin-3-yl)-pyridine which is reacted with acid and alcohol to obtain the 2,2-dimethoxy-2-(3-pyridinyl) ethyl-amine which is reacted with an amide and cyclized; intermediates are not isolated |
03/05/2002 | US6353017 Inhibitors of cathespins using dipeptide nitriles as antiinflammatory agents and antiarthritic agents |
03/05/2002 | US6352994 Nervous system disorders; psychological disorders |
03/05/2002 | US6352981 Treat disorders which respond to dopamine d.sub.3 ligands such as schistosomiasis, schizophrenia, depression, neuroses or psychoses |
03/05/2002 | US6352635 Halogen substituents in the 5-position of 4-amino-3-halopicolinic acids are selectively reduced by electrolysis. |
03/05/2002 | CA2049850C 4-substituted dihydropyrido[4,3-d]pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders |
02/28/2002 | WO2002016324A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
02/28/2002 | WO2002016322A2 Process for the preparation of 2-aminoethylpyridines |
02/28/2002 | WO2002016319A1 Novel thiourea compounds and the pharmaceutical compositions containing the same |
02/28/2002 | WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |